Illumina lodged an appeal at the EU courts on Wednesday contesting the European Commission’s imposition of interim measures related to its Grail acquisition, MLex has learned.The US gene-sequencing company is challenging the EU merger regulator's measures of Oct. 29, which it imposed following Illumina's decision to forge ahead with its acquisition of the